Citation: | Wang Chao, Li Tao, Zhang Jian, et al. Trend analysis of malignant tumor after renal transplantation in China[J]. ORGAN TRANSPLANTATION, 2015, 6(3): 169-173. doi: 10.3969/j.issn.1674-7445.2015.03.008 |
[1] |
解俊杰, 钱叶勇, 石炳毅, 等.肾移植患者术后并发原肾恶性肿瘤3例报告及文献复习[J].器官移植, 2012, 3(3):163-167. http://www.organtranspl.com/browse/detail/cat/32/id/600
Xie JJ, Qian YY, Shi BY, et al. The native kidney malignancy in post-renal transplant patients:a report of three cases and literature review[J]. Organ Transplant, 2012, 3(3):163-167. http://www.organtranspl.com/browse/detail/cat/32/id/600
|
[2] |
牛斌, 林静, 陈晓瑜, 等.肾移植术后新发恶性肿瘤临床分析[J].器官移植, 2013, 4(2):91-94. http://www.organtranspl.com/browse/detail/cat/32/id/309
Niu B, Lin J, Chen XY, et al. Clinical analysis of de novo malignancies after renal transplantation[J]. Organ Transplant, 2013, 4(2):91-94. http://www.organtranspl.com/browse/detail/cat/32/id/309
|
[3] |
Kapoor A.Malignancy in kidney transplant recipients[J]. Drugs, 2008, 68(Suppl 1):11-19. doi: 10.2165/00003495-200868001-00003?view=classic
|
[4] |
Zhang J, Ma L, Xie Z, et al. Epidemiology of post-transplant malignancy in Chinese renal transplant recipients:a single-center experience and literature review[J]. Med Oncol, 2014, 31(7):32. doi: 10.1007/s12032-014-0032-6
|
[5] |
范昱, 谈鸣岳.肾移植后恶性肿瘤58例的治疗体会[J].中华器官移植杂志, 2009, 30(1):34-36. http://d.wanfangdata.com.cn/Periodical/zhqgyz98200901008
Fan Y, Tan MY. Clinical experience in treatment of malignant tumors after kidney transplantation[J]. Chin J Organ Transplant, 2009, 30(1):34-36. http://d.wanfangdata.com.cn/Periodical/zhqgyz98200901008
|
[6] |
郝俊文, 宋华, 常征, 等.肾移植术后恶性肿瘤39例临床分析[J].肿瘤研究与临床, 2012, 24(1):38-40. http://d.wanfangdata.com.cn/Periodical/zlyjylc201201011
Hao JW, Song H, Chang Z, et al. Clinical study of 39 patients with malignant tumor after renal transplantation[J]. Cancer Res Clin, 2012, 24(1):38-40. http://d.wanfangdata.com.cn/Periodical/zlyjylc201201011
|
[7] |
于立新, 苗芸, 邓文锋, 等.肾移植受者新发恶性肿瘤的生存分析[J].中华器官移植杂志, 2010, 31(5):265-268. http://d.wanfangdata.com.cn/Periodical/zhqgyz98201005003
Yu LX, Miao Y, Deng WF, et al. De novo cancers in kidney transplant recipients[J]. Chin J Organ Transplant, 2010, 31(5):265-268. http://d.wanfangdata.com.cn/Periodical/zhqgyz98201005003
|
[8] |
相华, 张辉, 荣景, 等.肾移植术后并发恶性肿瘤10例[J].中华器官移植杂志, 2007, 28(10):616. http://d.wanfangdata.com.cn/Periodical/zhqgyz98200710024
Xiang H, Zhang H, Rong J, et al. Malignant tumor after renal transplantation:a report of 10 cases[J]. Chin J Organ Transplant, 2007, 28(10):616. http://d.wanfangdata.com.cn/Periodical/zhqgyz98200710024
|
[9] |
王海, 纪志刚, 薛翀, 等.肾移植术后恶性肿瘤:14例病例[J].癌症进展, 2009, 7(6):665-668. http://www.cnki.com.cn/Article/CJFDTOTAL-AZJZ200906022.htm
Wang H, Ji ZG, Xue C, et al. Malignancies after kidney transplantation:analysis of 14 cases[J]. Oncol Prog, 2009, 7(6):665-668. http://www.cnki.com.cn/Article/CJFDTOTAL-AZJZ200906022.htm
|
[10] |
徐小明, 张岩, 徐自强, 等.肾移植受者并发恶性肿瘤34例临床分析[J/CD].中华移植杂志:电子版, 2012, 6(2):97-104.
Xu XM, Zhang Y, Xu ZQ, et al. Profiles of malignant tumors following kidney transplantation:an analysis of 34 cases[J/CD]. Chin J Transplant:Electr Edit, 2012, 6(2):97-104.
|
[11] |
俞欣, 徐东亮, 柏金明, 等.肾移植术后恶性肿瘤15例临床分析[J].南京医科大学学报:自然科学版, 2010, 30(9):1330-1332. http://www.cnki.com.cn/Article/CJFDTOTAL-NJYK201009033.htm
Yu X, Xu DL, Bai JM, et al. Malignant tumors after renal transplantation:an clinical analysis of 15 cases[J]. Acta Univ Med Nanjing:Nat Sci, 2010, 30(9):1330-1332. http://www.cnki.com.cn/Article/CJFDTOTAL-NJYK201009033.htm
|
[12] |
曹文军, 刘致中, 李建新, 等.肾移植术后并发恶性肿瘤11例临床分析[J].中国当代医药, 2012, 19(2):22-24. http://www.cnki.com.cn/Article/CJFDTOTAL-ZGUD201202015.htm
Cao WJ, Liu ZZ, Li JX, et al. Clinical analysis of malignant tumors after kidney transplantation[J]. Chin Mod Med, 2012, 19(2):22-24. http://www.cnki.com.cn/Article/CJFDTOTAL-ZGUD201202015.htm
|
[13] |
马永文, 王东文, 石韶华, 等.肾移植术后恶性肿瘤的临床分析[J].实用医技杂志, 2011, 18(8):793-794. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYJ201108004.htm
Ma YW, Wang DW, Shi SH, et al. The clinical research of malignant tumor after renal transplantation[J]. J Prac Med Techn, 2011, 18(8):793-794. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYJ201108004.htm
|
[14] |
Raiola AM, Dominietto A, Ghiso A, et al. Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning[J]. Biol Blood Marrow Transplant, 2013, 19(1):117-122. doi: 10.1016/j.bbmt.2012.08.014
|
[15] |
Karczewski M, Czapiewski W, Karczewski J. Urologic de novo malignancies after kidney transplantation:a single center experience[J].Transplant Proc, 2012, 44(5):1293-1297. doi: 10.1016/j.transproceed.2011.11.063
|
[16] |
Cheung CY, Lam MF, Chu KH, et al. Malignancies after kidney transplantation:Hong Kong renal registry[J]. Am J Transplant, 2012, 12(11):3039-3046. doi: 10.1111/j.1600-6143.2012.04209.x
|
[17] |
Elkentaoui H, Robert G, Pasticier G, et al. Therapeutic management of de novo urological malignancy in renal transplant recipients:the experience of the French Department of Urology and Kidney Transplantation from Bordeaux[J]. Urology, 2010, 75(1):126-132. doi: 10.1016/j.urology.2009.06.106
|
[18] |
Andrés A. Cancer incidence after immunosuppressive treatment following kidney transplantation[J]. Crit Rev Oncol Hematol, 2005, 56(1):71-85. doi: 10.1016/j.critrevonc.2004.11.010
|
[19] |
赵平, 程万青. 2009年中国肿瘤登记年报[M].北京:军事医学科学出版社, 2010:42-54, 62-65.
Zhao P, Cheng WQ. Chinese cancer registry annual report 2009[M]. Beijing:Military Medical Science Press, 2010:42-54, 62-65.
|
[20] |
彭明强, 杨志豪, 方自林, 等.国内公开报道的肾移植后并发恶性肿瘤病例的总结分析[J].中华器官移植杂志, 2005, 26(5):269-271. http://www.cnki.com.cn/Article/CJFDTOTAL-ZHQG200505003.htm
Peng MQ, Yang ZH, Fang ZL, et al. An assemble analysis of malignancy following renal transplantation in China[J]. Chin J Organ Transplant, 2005, 26(5):269-271. http://www.cnki.com.cn/Article/CJFDTOTAL-ZHQG200505003.htm
|
[21] |
Hwang JK, Moon IS, Kim JI. Malignancies after kidney transplantation:a 40-year single-center experience in Korea[J]. Transpl Int, 2011, 24(7):716-721. doi: 10.1111/tri.2011.24.issue-7
|
[22] |
Navarro MD, López-Andréu M, Rodríguez-Benot A, et al. Cancer incidence and survival in kidney transplant patients[J]. Transplant Proc, 2008, 40(9):2936-2940. doi: 10.1016/j.transproceed.2008.09.025
|
[23] |
Puttarajappa C, Yabes J, Bei L, et al. Cancer risk with alemtuzumab following kidney transplantation[J].Clin Transplant, 2013, 27(3):E264-E271. doi: 10.1111/ctr.2013.27.issue-3
|
[24] |
Stratta P, Morellini V, Musetti C, et al. Malignancy after kidney transplantation:results of 400 patients from a single center[J]. Clin Transplant, 2008, 22(4):424-427. doi: 10.1111/ctr.2008.22.issue-4
|
[25] |
Kyllönen L, Salmela K, Pukkala E. Cancer incidence in a kidney-transplanted population[J]. Transpl Int, 2000, 13(Suppl 1):S394-S398. doi: 10.1007/s001470050369
|
[26] |
Kasiske BL, Snyder JJ, Gilbertson DT, et al. Cancer after kidney transplantation in the United States[J]. Am J Transplant, 2004, 4(6):905-913. doi: 10.1111/ajt.2004.4.issue-6
|
[27] |
Villeneuve PJ, Schaubel DE, Fenton SS, et al. Cancer incidence among Canadian kidney transplant recipients[J]. Am J Transplant, 2007, 7(4):941-948. doi: 10.1111/ajt.2007.7.issue-4
|
[28] |
Hoshida Y, Tsukuma H, Yasunaga Y, et al. Cancer risk after renal transplantation in Japan[J]. Int J Cancer, 1997, 71(4):517-520. doi: 10.1002/(ISSN)1097-0215
|
[29] |
Shin M, Moon HH, Kim JM, et al. Comparison of the incidence of de novo malignancy in liver or kidney transplant recipients:analysis of 2673 consecutive cases in a single center[J]. Transplant Proc, 2013, 45(8):3019-3023. doi: 10.1016/j.transproceed.2013.08.061
|
[30] |
肖荆.马兜铃酸与肾移植患者术后并发尿路上皮癌关系及Ras、P53基因突变影响的研究[J].现代泌尿外科杂志, 2011, 16(5):480-482. http://www.cnki.com.cn/Article/CJFDTOTAL-MNWK201105040.htm
Xiao J. Research on relationship between aristolochic acid and postoperative urothelial carcinoma in renal transplant and the Ras and P53 gene mutation[J]. J Mod Urol, 2011, 16(5):480-482. http://www.cnki.com.cn/Article/CJFDTOTAL-MNWK201105040.htm
|
[31] |
陈瑜, 张雷, 王立明, 等.马兜铃酸肾病患者肾移植术后继发双侧尿路肿瘤一例[J].中华器官移植杂志, 2011, 32(5):271. http://d.wanfangdata.com.cn/Periodical/zhqgyz98201105005
Chen Y, Zhang L, Wang LM, et al. Aristolochic acid nephropathy after renal transplantation in patients with secondary bilateral urinary tract tumors:a report of 1 case[J]. Chin J Organ Transplant, 2011, 32(5):271. http://d.wanfangdata.com.cn/Periodical/zhqgyz98201105005
|
[32] |
杨宏伟, 刘龙.马兜铃酸肾病肾移植术后并发泌尿系肿瘤5例并文献复习[J].现代泌尿生殖肿瘤杂志, 2011, 3(1):45. http://www.cnki.com.cn/Article/CJFDTOTAL-PXDM201101021.htm
Yang HW, Liu L. Aristolochic acid nephropathy complicated urinary tumor tract after renal transplantation:a report of 5 cases and literature review[J]. J Contemp Urol Reprod Oncol, 2011, 3(1):45. http://www.cnki.com.cn/Article/CJFDTOTAL-PXDM201101021.htm
|
[33] |
Zustovich F, Ferro A, Toso S. Gemcitabine for the treatment of classic Kaposi's sarcoma:a case series[J]. Anticancer Res, 2013, 33(12):5531-5534. http://cn.bing.com/academic/profile?id=2341146596&encoded=0&v=paper_preview&mkt=zh-cn
|
[34] |
郭继华, 王俊, 孟伟, 等.肾移植后卡波西肉瘤临床病理观察[J].中国癌症杂志, 2006, 16(5):351-353. http://www.cnki.com.cn/Article/CJFDTOTAL-ZGAZ200605006.htm
Guo JH, Wang J, Meng W, et al. Clinicopathological changes of renal transplantation related Kaposi's sarcoma[J]. Chin Oncol, 2006, 16(5):351-353. http://www.cnki.com.cn/Article/CJFDTOTAL-ZGAZ200605006.htm
|